Heligenics - Connecting Mutations to Health

Heligenics is a life sciences company that has developed proprietary technology, which shows the impact of genetic mutations to revolutionize genetic testing and drug development for major diseases. We are the first company to develop High Content Screening for Biologic Drugs, previously the mainstay for the development of small compound drugs. As the effect of most mutations on gene function is largely unknown, Heligenics comprehensively measures the functional significance of mutations in the human genome through a massively parallel in-vitro process called the GigaAssay, measuring the impact of all potential amino acid substitutions in the functional target protein, doing in a few months what would take many years to do if at all. For cancer diagnostics companies, our functional data enables improved genetic test interpretation, and for pharmaceutical companies, we empower the conversion of generic drugs into targeted precision medicines or can rescue a failed drug candidate through the identification of variants for a redesigned genetically stratified clinical trial. Explore more! Email: mschiller@heligenics.com Website: Heligenics.com LinkedIn: linkedin.com/company/heligenics-inc/ Twitter: twitter.com/heligenics